A short, 60 seconds read that summarises 4 handpicked articles that are worth reading about:
Can Orphan Status Pave the Way for Higher Prices in the UK?
Italy: AIFA reports on manufacturer paybacks
UK: DHSC launches consultation on proposal to revise payment percentage paid by companies under statutory scheme for branded medicine pricing
Europe: PRIME scheme has positive impact on the authorisation of new medicines – report